HemoSphere will provide a virtual environment for simulations of cellular blood flow in microfluidic devices, lab-on-a-chip, organ-on-a-chip, and other biochips or blood-processing and analysis technology. It will make novel scientific simulation methods and HPC resources available for use in device development. Simulation models will run on HPC resources in the background of HemoSphere. HPC or simulation expertise are not required. HemoSphere will be able to be readily applied by device engineers as a virtual prototyping tool to rapidly and accurately predict the processes in the device. The number of physical prototypes that need to be manufactured and tested can be dramatically reduced this way.
Partial Funding from the EU
This form of simulation-as-a-service, combining novel simulation techniques with HPC resources and an accessible interface/workflow, is very unique and technically demanding, however it gives innovative SMEs access to HPC simulation technology and this will have a positive effect on the European economy. Therefore the European Commission supports us in this challenge with funding through the FP7 project Fortissimo, a large consortium of service providers, end-users and HPC centers, pushing the accessibility of HPC simulation techniques for SME and industrial users forward.